ScheBo® • Biotech
An innovative biotechnology company active in the development, production, and marketing of in-vitro diagnostics.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
ScheBo® • Biotech AG is an innovative, globally active biotechnology company specializing in the development, production, and marketing of in-vitro diagnostics. Founded in 1989 by biochemists and molecular biologists Dr. Ursula Scheefers-Borchel and Dr. Hans Scheefers, the company is self-financed and independent. It focuses on the production of monoclonal antibodies against various antigens, the development of routine test systems (e.g., ELISA systems, lateral flow tests), and the identification and isolation of target proteins. The company holds national and international patents and operates internationally.
History
ScheBo® • Biotech AG was founded in 1989 by biochemists and molecular biologists Dr. Ursula Scheefers-Borchel and Dr. Hans Scheefers. The company is specialized in the production of monoclonal antibodies against various antigens, the development of routine test systems (e.g., ELISA systems, lateral flow tests), and the identification and isolation of target proteins. It is self-financed and therefore independent. The company is internationally active and offers innovative products that hold a globally unique position in the field of in-vitro diagnostics.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/schebo-biotech · Editorial policy · How profiles are compiled